dihydroergotamine has been researched along with cp 122288 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castanon, N; Chauveau, J; Chaveau, J; Hen, R; Macor, JE; Moskowitz, MA; Scearce, K; Waeber, C; Yu, XJ | 1 |
| Hargreaves, RJ; Williamson, DJ | 1 |
1 review(s) available for dihydroergotamine and cp 122288
| Article | Year |
|---|---|
Neurogenic inflammation in the context of migraine.
Topics: Animals; Blood Proteins; Bosentan; Calcitonin Gene-Related Peptide; Capillary Permeability; Dihydroergotamine; Dura Mater; Humans; Migraine Disorders; Narcotics; Neurogenic Inflammation; Neurokinin-1 Receptor Antagonists; Pyrrolidines; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT1F; Receptors, Neurokinin-1; Receptors, Serotonin; Serotonin Receptor Agonists; Skull; Sulfonamides; Sumatriptan; Trigeminal Nerve; Vasoconstrictor Agents; Vasodilation | 2001 |
1 other study(ies) available for dihydroergotamine and cp 122288
| Article | Year |
|---|---|
5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
Topics: Animals; Capillary Permeability; Dihydroergotamine; Dipeptides; Mice; Mice, Knockout; Pyridines; Pyrroles; Pyrrolidines; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Ganglion | 1996 |